Globeflex Capital’s Genomic Health, Inc. GHDX Stock Holding History

Globeflex Capital’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-33,872	Closed	-$1.97M	–	558
2019 Q2	$1.97M	Sell	33,872 -39	-0.1%	-$2.31K	0.41%	49
2019 Q1	$2.38M	Buy	33,911 +11,538	+52%	+$856K	0.5%	36
2018 Q4	$1.44M	Buy	22,373 +8,749	+64%	+$613K	0.34%	86
2018 Q3	$957K	Buy	13,624 +11,324	+492%	+$662K	0.19%	188
2018 Q2	$116K	Buy	+2,300	New	+$91.3K	0.02%	408
2017 Q1	–	Sell	-10,749	Closed	-$316K	–	595
2016 Q4	$316K	Buy	+10,749	New	+$328K	0.08%	314

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Globeflex Capital's GHDX Position: Q3 2019 in Review

Globeflex Capital sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 33,872 shares — an estimated $1.97M sold.

Globeflex Capital first reported a position in GHDX in Q4 2016 and held it in 6 quarters. The position peaked at $2.38M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

Globeflex Capital reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
Globeflex Capital sold 33,872 Genomic Health, Inc. shares in Q3 2019, an estimated $1.97M.
Globeflex Capital first reported a position in Genomic Health, Inc. in Q4 2016 and held it in 6 quarters.
Globeflex Capital's Genomic Health, Inc. position peaked at $2.38M in Q1 2019.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Globeflex Capital's 13F filing for Q3 2019, filed 13 Nov 2019.